Clinical Trial Update: Randomized Comparative Study of Erlotinib and Pemetrexed in the Maintenance Treatment of Advanced Lung Cancer Patients. [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial comparing erlotinib versus pemetrexed in maintenance treatment for advanced non-small cell lung cancer; the study has terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Carcinoma

Drugs mentioned

• ERLOTINIB (Erlotinib)
• Pemetrexed (pemetrexed)

Snippet

Sponsor: Hikma Pharmaceuticals LLC | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 4 | Status: TERMINATED